Contraception News and Research RSS Feed - Contraception News and Research

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
Lancet study highlights long-term effect of 1999 nationwide strategy to reduce teenage pregnancy

Lancet study highlights long-term effect of 1999 nationwide strategy to reduce teenage pregnancy

Rates of teenage pregnancy in England have halved since the implementation of the Government's Teenage Pregnancy Strategy (TPS) in 1999, and the greatest effect is seen in areas of high deprivation and areas that received the most TPS funding, according to research published in The Lancet. [More]
Abortion rates at all-time low in developed countries, but unchanged in the developing world

Abortion rates at all-time low in developed countries, but unchanged in the developing world

Abortion rates have dropped to an all-time low in developed countries, but remain the same in developing countries, where it is often unsafe to have an abortion, report researchers. [More]
Lancet study finds unsafe sex as fastest-growing risk factor for ill health in young people

Lancet study finds unsafe sex as fastest-growing risk factor for ill health in young people

The Lancet Commission's groundbreaking report released today, "Our Future: A Lancet Commission on Adolescent Health and Wellbeing," finds that years of neglect and underinvestment have had serious detrimental effects on the health and wellbeing of adolescents aged 10-24 years. [More]
Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress. [More]
Hormonal contraception may increase susceptibility of women to genital infection

Hormonal contraception may increase susceptibility of women to genital infection

Women account for approximately half of all individuals living with HIV worldwide, and researchers wanted to identify the risk factors that increase susceptibility of women to genital infection. [More]
Women with epilepsy have likelihood of achieving successful pregnancy just as healthy peers

Women with epilepsy have likelihood of achieving successful pregnancy just as healthy peers

Women with epilepsy are just as likely to achieve a successful pregnancy as women without the neurological disorder, according to a new study led by research teams at multiple centers, including NYU Langone Medical Center. [More]
Researchers reach milestone in developing non-hormonal approach to male contraception

Researchers reach milestone in developing non-hormonal approach to male contraception

Researchers studying strategies to develop a non-hormonal approach to male contraception have reached an important milestone in their work, discovering a way to produce a key enzyme found only in sperm in sufficient quantities that they can begin designing drugs to stop the sperm from swimming to the egg. [More]
Spending less than $5 per person could save millions of maternal, child lives every year

Spending less than $5 per person could save millions of maternal, child lives every year

By spending less than $5 per person on essential health care services such as contraception, medication for serious illnesses and nutritional supplements, millions of maternal and child lives could be saved every year, according to a new analysis led by the Johns Hopkins Bloomberg School of Public Health. [More]
Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

The risk in terms of the Olympics, especially for travelling populations remains low – with the notable exception of pregnant women. [More]
Oregon's new birth control law could improve access to all forms of contraception

Oregon's new birth control law could improve access to all forms of contraception

Researchers at Oregon Health & Science University, University of Minnesota School of Public Health and George Mason University applaud Oregon's new birth control law which allows women age 18 or older to obtain some methods of hormonal contraception directly from pharmacies, without having to visit a prescribing clinician, yet note how the law could go even further to improve access to all forms of contraception, according to a viewpoint article published in the Journal of the American Medical Association today. [More]
Simple tool for inserting intrauterine device may offer low-cost option for long-term contraception

Simple tool for inserting intrauterine device may offer low-cost option for long-term contraception

A simple tool designed for inserting an intrauterine device may offer women in the developing world a convenient, low-cost option for long-term contraception. [More]
Oral contraceptives increase rare stroke risk in obese women

Oral contraceptives increase rare stroke risk in obese women

Researchers have found that obese women taking oral contraceptives have an increased risk of cerebral venous thrombosis and should be educated about this risk accordingly. [More]
Researchers aim to design a better male contraceptive pill

Researchers aim to design a better male contraceptive pill

Women can choose from a wide selection of birth control methods, including numerous oral contraceptives, but there's never been an analogous pill for men. That's not for lack of trying: For many years, scientists have attempted to formulate a male pill. Finally, a group of researchers has taken a step toward that goal by tweaking some experimental compounds that show promise. [More]
New research reveals European women's attitudes towards sexual behaviours, emergency contraceptive pill

New research reveals European women's attitudes towards sexual behaviours, emergency contraceptive pill

New research released on International Women’s Day, reveals more than three in four European women (77%) are aware of the morning after pill as an option for managing the risk of an unplanned pregnancy after unprotected sex or contraceptive failure. [More]
New study assesses link between depression, anxiety and antidepressants and outcome of IVF

New study assesses link between depression, anxiety and antidepressants and outcome of IVF

Depression and anxiety, and not necessarily the use of antidepressant medication, are associated with lower pregnancy and live birth rates following in vitro fertilisation, according to a large register study from Karolinska Institutet in Sweden. The findings are published in the journal Fertility & Sterility and can be of interest to clinicians treating infertility and for women with depression or anxiety planning to undergo fertility treatment. [More]
Woman's Condom prequalified by WHO/UNFPA

Woman's Condom prequalified by WHO/UNFPA

The Woman's Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization/United Nations Population Fund. The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV. [More]
Preventing the spread of Zika: an interview with Professor John Oxford

Preventing the spread of Zika: an interview with Professor John Oxford

The link between the Zika virus and Guillain-Barré on the one hand, and pregnancy and the virus affecting the fetus in terms of microcephaly on the other, is still not confirmed conclusively. [More]
NOF provides evidence-based guidance to help children and adolescents attain optimal bone health

NOF provides evidence-based guidance to help children and adolescents attain optimal bone health

The National Osteoporosis Foundation today released a position statement providing evidence-based guidance and a national implementation strategy to help children and adolescents achieve optimal bone health, or what is known as "peak bone mass," early in life. [More]
Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai Inc. announced today that the U.S. Food and Drug Administration approved Halaven (eribulin mesylate) Injection (0.5 mg per mL) for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen. [More]
Advertisement
Advertisement